Misleading ads case: Acharya Balkrishna, Patanjali say sorry to SC
Balakrishna says the intention was to only promote a healthier life; assures not to create such ads in future
Balakrishna says the intention was to only promote a healthier life; assures not to create such ads in future
SC in February had asked Patanjali Ayurved to stop promoting and marketing ayurvedic products, which it claimed to cure critical illnesses
SC bars Patanjali Ayurved from promoting and marketing products that claim to cure critical illnesses like heart issues and asthma
Rajiv Jain-led GQG has acquired a 5.96% stake, or about 2.15 crore shares, in Patanjali Foods in the recently concluded offer for sale (OFS) of the FMCG company.
The OFS, at floor price of ₹1,000 apiece, will fetch around ₹3,258 crore to Baba Ramdev-led Patanjali Ayurved.
Promoter shareholding in Patanjali Foods currently stands at 80.82%.
The four companies that will list on the bourses include - Patanjali Ayurved, Patanjali Medicine, Patanjali Wellness and Patanjali Lifestyle.
The Patanjali Ayurved-owned company's stock jumped 14.71% to ₹938 apiece on the National Stock Exchange.
A little help from lenders facilitated Ruchi Soya’s follow-on public offer.
Shares of Ruchi Soya rallied as much as 20% even after its ₹4,300 crore follow-on public offering faces a regulatory hurdle.